The treatment of multidrug-resistant Gram-negative bacteria (MDR-GNB) infections in critically ill patients presents many challenges. Since an effective treatment should be administered as soon as possible. resistance to many antimicrobial classes almost invariably reduces the probability of adequate empirical coverage. with possible unfavorable consequences. https://www.alarecre.com/